Jim Simons Protalix Bio Therapeutics, Inc. Put Options Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PLX
# of Institutions
68Shares Held
8.72MCall Options Held
168KPut Options Held
31.4K-
Northern Trust Corp Chicago, IL1.08MShares$2.09 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA826KShares$1.6 Million0.0% of portfolio
-
Connor, Clark & Lunn Investment Management Ltd.496KShares$962,6590.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA485KShares$940,5080.0% of portfolio
-
Morgan Stanley New York, NY462KShares$896,3630.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $96.5M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...